| Analysis | Metabolite Name | Measured Value | Units | Diagnosis | Dysplasia |
|---|---|---|---|---|---|
| 6530 Q-TOF/C18 NEGATIVE ION MODE | GLUTAMIC ACID (M-H)- | 9608 | Peak area | IPMN | LGD |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | GLUTAMIC ACID (M-H)- | 13725 | Peak area | MCN | LGD |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | GLUTAMIC ACID (M-H)- | 15331 | Peak area | SCA | N/A |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | GLUTAMIC ACID (M-H)- | 110976 | Peak area | SCA | N/A |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | GLUTAMIC ACID (M-H)- | Peak area | IPMN | LGD | |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | GLUTAMIC ACID (M-H)- | Peak area | MCN | LGD | |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | GLUTAMIC ACID (M-H)- | Peak area | SCA | N/A | |
| 6530 Q-TOF/C18 POSITIVE ION MODE | GLUTAMIC ACID (M+H)+ | 1930 | Peak area | SCA | N/A |
| 6530 Q-TOF/C18 POSITIVE ION MODE | GLUTAMIC ACID (M+H)+ | 3530 | Peak area | SCA | N/A |
| 6530 Q-TOF/C18 POSITIVE ION MODE | GLUTAMIC ACID (M+H)+ | Peak area | IPMN | LGD | |
| 6530 Q-TOF/C18 POSITIVE ION MODE | GLUTAMIC ACID (M+H)+ | Peak area | MCN | LGD | |
| 6530 Q-TOF/C18 POSITIVE ION MODE | GLUTAMIC ACID (M+H)+ | Peak area | SCA | N/A | |
| 6530 Q-TOF/C18 POSITIVE ION MODE | GLUTAMIC ACID (M+H)+[-H2O] | 7878 | Peak area | IPMN | LGD |
| 6530 Q-TOF/C18 POSITIVE ION MODE | GLUTAMIC ACID (M+H)+[-H2O] | 15657 | Peak area | SCA | N/A |
| 6530 Q-TOF/C18 POSITIVE ION MODE | GLUTAMIC ACID (M+H)+[-H2O] | Peak area | IPMN | LGD | |
| 6530 Q-TOF/C18 POSITIVE ION MODE | GLUTAMIC ACID (M+H)+[-H2O] | Peak area | MCN | LGD | |
| 6530 Q-TOF/C18 POSITIVE ION MODE | GLUTAMIC ACID (M+H)+[-H2O] | Peak area | SCA | N/A |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|